AFP global news director Michèle Léridon receives the "Investigation and Reporting" prize at the International Congress for Journalism and Information

The student jury of the 8th International Congress for Journalism and Information awarded the prize to global news director Michèle Léridon for her article "Covering the Islamic State" which was published on AFP’s Correspondent blog.

Correspondent Blog

Satellites

AFP effects its first satellite news transmission.
04/24/2025 12:00
Mantle Index Four (MI4) Fund Launches with Securitize as Tokenization Partner and Mantle Treasury as Anchor Investor

Mantle, a leading blockchain ecosystem at the forefront of decentralized finance (DeFi) with over $3 billion in Total Value Locked (TVL) across its core products, today announced the launch of the Mantle Index Four (MI4) Fund. MI4 fills a key market gap: an institutional-grade crypto product with native yield generation, structured within a traditional fund format. Tailored for both crypto-native and traditional investors, MI4 offers access to leading digital assets without the operational comp...

04/24/2025 12:00
Curiosity Cube 2025: Merck’s Mobile Science Labs Tour Globally to Bring STEM Education to Students

Merck, a leading science and technology company, today launched its global 2025 Curiosity Cube tour in Darmstadt, Germany. The solar-powered mobile science labs will bring hands-on STEM (science, technology, engineering and mathematics) experiences to students across Europe, North America, and for the first time, Africa. In 2025, the tour aims to reach 60,000 students worldwide. The initiative underscores Merck's commitment to inspiring enthusiasm for science and technology. Merck today also op...

06/05/2025 06:30
Fujirebio Announces Strategic Collaboration with Stanford Medicine to Advance Infectious Disease Research

Fujirebio, a leading innovator in in-vitro diagnostics, today announced a collaboration with Stanford Medicine (Location: Palo Alto, California, USA) to advance research and innovation in the field of infectious disease testing. This collaboration aims to accelerate the adoption of ultrasensitive immunoassays that incorporate single-molecule counting technology developed by Fujirebio’s Silicon Valley wholly-owned subsidiary, Fluxus, Inc. Greater test sensitivity can better inform...